SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-05-214815
Filing Date
2005-11-03
Accepted
2005-11-03 06:18:06
Documents
4
Period of Report
2005-10-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 21101
2 CONVERSION AND PLACEMENT AGREEMENT dex101.htm EX-10.1 208447
3 PRESS RELEASE dex991.htm EX-99.1 20616
4 GRAPHIC g36820img_01.jpg GRAPHIC 1929
  Complete submission text file 0001193125-05-214815.txt   254556
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 051174853
SIC: 2834 Pharmaceutical Preparations